|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01828 FWD
Nominal 
33.920 +0.080 (+0.236%) | 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Insurance Revenue | 2,911,000 | 6.865% | 2,724,000 | 2,756,000 | 2,408,000 |
| Interest Income | 1,403,000 | 18.397% | 1,185,000 | 1,159,000 | 1,011,000 |
| Turnover | -- | -- | -- | -- | -- |
| Gross Premium Income | -- | -- | -- | -- | -- |
| Net Premium Income | -- | -- | -- | -- | -- |
| Investment Income/(Loss) | 504,000 | 441.935% | 93,000 | (791,000) | (999,000) |
| Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- | -- |
| Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- | -- |
| Other Income/(Loss) | 23,000 | -36.111% | 36,000 | 64,000 | 38,000 |
| Total Revenues | 4,841,000 | 19.886% | 4,038,000 | 3,188,000 | 2,458,000 |
| Insurance Service Expenses | (2,050,000) | 1.889% | (2,012,000) | (1,989,000) | (1,817,000) |
| Net Expenses from Reinsurance Contracts | (26,000) | -38.095% | (42,000) | (88,000) | (146,000) |
| Net Finance (Expenses)/Income from Insurance Contracts | (1,775,000) | 68.887% | (1,051,000) | (996,000) | 86,000 |
| Net Finance (Expenses)/Income from Reinsurance Contracts | 66,000 | 112.903% | 31,000 | 1,000 | (23,000) |
| Net Impairment Loss | (6,000) | -62.500% | (16,000) | (9,000) | (29,000) |
| Other Expenses | (759,000) | -5.125% | (800,000) | (901,000) | (815,000) |
| Other Non-operating Items | -- | -- | -- | -- | -- |
| Share of results of Associates & JCEs | 31,000 | -13.889% | 36,000 | (20,000) | 2,000 |
| Profit / (Loss) before Taxation | 322,000 | 75.000% | 184,000 | (814,000) | (284,000) |
| Taxation | (162,000) | -6.897% | (174,000) | 97,000 | (36,000) |
| Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- |
| Non-controlling Interests | 6,000 | -57.143% | 14,000 | 1,000 | 101,000 |
| Others | (62,000) | -39.216% | (102,000) | (110,000) | (83,000) |
| Profit/ (Loss) Attributable to Shareholders | 104,000 | -- | (78,000) | (826,000) | (302,000) |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Depreciation & Amortisation | 102,000 | -2.857% | 105,000 | 105,000 | 95,000 |
| Directors' Emoluments | 8,580 | 40.179% | 6,121 | 6,811 | 6,474 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 12.880 | -- | -18.260 | -- | -- |
| DPS (cts) | 0.000 | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.316 | -- | 1.679 | -- | -- |
| NBV per share ($) | 5.183 | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 16/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD 104,000 |
| %Change | -- |
| EPS / (LPS) | USD 0.129 |
| NBV Per Share ($) | USD 5.183 |